ELECTROMED, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 14.97 USD | +2.46% |
|
+5.65% | +37.21% |
| May. 07 | Transcript : Electromed, Inc., Q3 2024 Earnings Call, May 07, 2024 | |
| May. 07 | Electromed, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024 | CI |
Strengths
- The company's profit outlook over the next few years is a strong asset.
- Sales forecast by analysts have been recently revised upwards.
- For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
- For the past twelve months, EPS forecast has been revised upwards.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- The group usually releases upbeat results with huge surprise rates.
Weaknesses
- The firm trades with high earnings multiples: 29.35 times its 2024 earnings per share.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Advanced Medical Equipment & Technology
| 1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
|---|---|---|---|---|
| +37.21% | 126M | C | ||
| +7.32% | 217B | B | ||
| +13.83% | 194B | B- | ||
| +20.48% | 143B | B- | ||
| +31.33% | 111B | A- | ||
| +3.08% | 64.3B | A- | ||
| +14.64% | 52.94B | B+ | ||
| +2.72% | 49.53B | B+ | ||
| -5.88% | 38.31B | A | ||
| +0.25% | 35.22B | - |
Investor Rating
Trading Rating
-
ESG Refinitiv
Financials
Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances
-
Valuation
P/E ratio
EV / Sales
-
Price to Book
-
Price to Free Cash Flow
-
Yield
-
Momentum
1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision
Consensus
Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion
-
Business Predictability
Analyst Coverage
Divergence of Estimates
-
Divergence of analysts' opinions
-
Divergence of Target Price
-
Earnings quality
Environment
Emissions
Innovation
Use of resources
Governance
CSR Strategy
Management
Shareholders
Controversy
Controversy
Technical analysis
ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
- Stock Market
- Equities
- ELMD Stock
- Ratings Electromed, Inc.
